Endo Aims To Stabilize Generics Unit In 2021

Company Delivers Another Underwhelming Quarter

 
• By Akriti Seth
  
competition
Endo expects to see additional competition on its “higher revenue products” in 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business